Verastem, Inc.·4

Nov 25, 5:34 PM ET

Kauffman Michael 4

4 · Verastem, Inc. · Filed Nov 25, 2025

Insider Transaction Report

Form 4
Period: 2025-11-21
Kauffman Michael
DirectorPresident of Development
Transactions
  • Sale

    Common Stock

    2025-11-21$10.00/sh8,550$85,5008,666 total
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $10.00 through $10.01, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein.

Documents

1 file
  • 4
    tm2532206-3_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT